Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
29.84
+0.27 (0.91%)
At close: Jul 14, 2025, 2:57 PM CST

SHE:300937 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2019
2,8172,3943,0092,7614,358-
Upgrade
Market Cap Growth
6.06%-20.45%8.97%-36.64%--
Upgrade
Enterprise Value
2,8052,4062,9782,7284,281-
Upgrade
Last Close Price
29.4524.9331.0328.2944.66-
Upgrade
PE Ratio
250.44146.3250.5465.71680.87-
Upgrade
PS Ratio
0.660.550.680.701.28-
Upgrade
PB Ratio
3.352.813.523.375.53-
Upgrade
P/TBV Ratio
3.563.053.803.705.98-
Upgrade
P/FCF Ratio
14.1025.07-20.55--
Upgrade
P/OCF Ratio
12.2318.75-18.09--
Upgrade
EV/Sales Ratio
0.660.550.670.691.26-
Upgrade
EV/EBITDA Ratio
46.0949.7532.0135.22320.29-
Upgrade
EV/EBIT Ratio
90.3182.5240.2646.88117838.91-
Upgrade
EV/FCF Ratio
14.0425.20-20.31--
Upgrade
Debt / Equity Ratio
0.420.460.390.300.170.08
Upgrade
Debt / EBITDA Ratio
5.766.603.352.977.810.55
Upgrade
Debt / FCF Ratio
1.764.07-1.81-1.18
Upgrade
Asset Turnover
2.332.572.702.863.363.53
Upgrade
Inventory Turnover
8.067.428.088.017.998.24
Upgrade
Quick Ratio
0.940.870.800.830.630.60
Upgrade
Current Ratio
1.621.651.721.682.202.04
Upgrade
Return on Equity (ROE)
1.46%1.80%6.78%4.50%1.03%10.36%
Upgrade
Return on Assets (ROA)
1.06%1.07%2.82%2.62%0.00%4.94%
Upgrade
Return on Capital (ROIC)
1.57%1.50%4.11%3.67%0.00%7.15%
Upgrade
Return on Capital Employed (ROCE)
3.60%3.30%8.30%6.90%0.00%11.60%
Upgrade
Earnings Yield
0.40%0.68%1.98%1.52%0.15%-
Upgrade
FCF Yield
7.09%3.99%-5.01%4.87%-4.26%-
Upgrade
Dividend Yield
0.34%0.40%0.71%0.71%--
Upgrade
Payout Ratio
264.72%184.93%40.51%12.63%322.93%23.40%
Upgrade
Buyback Yield / Dilution
-0.27%-0.21%-0.56%-4.44%-26.94%-0.24%
Upgrade
Total Shareholder Return
0.07%0.19%0.15%-3.73%-26.94%-0.24%
Upgrade
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.